Impact of pharmacist intervention on the utilization of sitagliptin use in the ckd

• In: Poster presentation
• At: Seoul (South Korea) (2017)
• Type: Poster
• Poster code: POS-HPS-077
• By: LEE, Chi-Hui (China Taiwan)
• Co-author(s): Chi-Hui Lee
  
• Abstract:

  Background

  Sitagliptin is the first DPP-IV inhibitor and studies have demonstrated that appropriate reductions dose in chronic kidney disease (CKD) patients.

  Purpose

  This study was to evaluate the impacts of pharmacist intervention on sitagliptin utilization in chronic kidney disease .

  Methods

  This study was divided into three periods of repetitive..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login